180 related articles for article (PubMed ID: 29516208)
1. Time-dependent change in relapse sites of renal cell carcinoma after curative surgery.
Noguchi G; Nakaigawa N; Taguri M; Tsutsumi S; Saito Y; Fukui S; Yasui M; Tokita T; Mitome T; Tatenuma T; Kuroda S; Abe K; Ueno D; Namura K; Umemoto S; Takizawa A; Ohta J; Ueki T; Watanabe T; Kobayashi K; Kondo K; Kishida T; Kanno H; Kitami K; Yamanaka T; Yao M
Clin Exp Metastasis; 2018 Feb; 35(1-2):69-75. PubMed ID: 29516208
[TBL] [Abstract][Full Text] [Related]
2. Local salvage therapy for late (≥2 years) metastatic and local relapse of renal cell cancer is a potentially curative treatment irrespective of the site of recurrence.
Grüllich C; Vallet S; Hecht C; Duensing S; Hadaschik B; Jäger D; Hohenfellner M; Pahernik S
Urol Oncol; 2016 May; 34(5):238.e9-17. PubMed ID: 26739671
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
[TBL] [Abstract][Full Text] [Related]
4. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis.
Park YH; Baik KD; Lee YJ; Ku JH; Kim HH; Kwak C
BJU Int; 2012 Dec; 110(11 Pt B):E553-8. PubMed ID: 22578274
[TBL] [Abstract][Full Text] [Related]
5. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
6. [Chromophobe renal cell carcinoma: a clinicopathological study of 16 cases].
Nakaigawa N; Yao M; Kondo K; Kishida T; Noguchi K; Kubota Y; Nagashima Y; Kawano N; Inayama Y; Nozawa A
Hinyokika Kiyo; 2006 Jan; 52(1):1-6. PubMed ID: 16479980
[TBL] [Abstract][Full Text] [Related]
7. Understanding the role of salvage lymphadenectomy in node only recurrences after nephrectomy for renal cell carcinoma.
Barboza MP; Speir RW; Boris RS; Calaway AC; Cary C; Foster RS; Masterson TA
Urol Oncol; 2020 Sep; 38(9):739.e1-739.e8. PubMed ID: 32646691
[TBL] [Abstract][Full Text] [Related]
8. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
[TBL] [Abstract][Full Text] [Related]
9. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
10. Patient Reported Weight Loss Predicts Recurrence Rate in Renal Cell Cancer Cases after Nephrectomy.
Tiwari P; Kumar L; Thulkar S; Singh G; Malik P; Seth A
Asian Pac J Cancer Prev; 2018 Apr; 19(4):891-895. PubMed ID: 29693333
[TBL] [Abstract][Full Text] [Related]
11. Papillary renal cell carcinoma: clinicopathological characteristics and evaluation of prognosis in 42 patients.
Onishi T; Ohishi Y; Goto H; Suzuki M; Miyazawa Y
BJU Int; 1999 Jun; 83(9):937-43. PubMed ID: 10368232
[TBL] [Abstract][Full Text] [Related]
12. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.
Siddiqui SA; Frank I; Cheville JC; Lohse CM; Leibovich BC; Blute ML
BJU Int; 2009 Sep; 104(6):778-85. PubMed ID: 19338559
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of Renal Cell Cancer After Renal Transplantation in a Multicenter French Cohort.
Cognard N; Anglicheau D; Gatault P; Girerd S; Essig M; Hurault de Ligny B; Le Meur Y; Le Roy F; Garrouste C; Thierry A; Colosio C; Rivalan J; Sayegh J; Choukroun G; Moulin B; Caillard S
Transplantation; 2018 May; 102(5):860-867. PubMed ID: 29215458
[TBL] [Abstract][Full Text] [Related]
14. The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol.
Antonelli A; Cozzoli A; Zani D; Zanotelli T; Nicolai M; Cunico SC; Simeone C
BJU Int; 2007 Feb; 99(2):296-300. PubMed ID: 17326263
[TBL] [Abstract][Full Text] [Related]
15. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson EO; Lam TB; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Dabestani S; Bex A
Eur Urol Oncol; 2021 Jun; 4(3):473-482. PubMed ID: 33109495
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.
Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T
BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of F-18 FDG PET/CT for local and distant disease relapse surveillance in surgically treated RCC patients: Can it aid in establishing consensus follow up strategy?
Elahmadawy MA; Elazab MSS; Ahmed S; Salama M
Nucl Med Rev Cent East Eur; 2018; 21(2):85-91. PubMed ID: 30070347
[TBL] [Abstract][Full Text] [Related]
18. Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach.
Stewart-Merrill SB; Thompson RH; Boorjian SA; Psutka SP; Lohse CM; Cheville JC; Leibovich BC; Frank I
J Clin Oncol; 2015 Dec; 33(35):4151-7. PubMed ID: 26351352
[TBL] [Abstract][Full Text] [Related]
19. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.
Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH
World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251
[TBL] [Abstract][Full Text] [Related]
20. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
